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Abstract
The clinical use of benzodiazepines (BZs) is hampered by sedation and cognitive deterioration. Although
genetic and pharmacological studies suggest that a1- and a5-containing GABAA receptors mediate and/or
modulate these eﬀects, their molecular substrate is not fully elucidated. By the use of two selective
ligands : the a1-subunit aﬃnity-selective antagonist b-CCt, and the a5-subunit aﬃnity- and eﬃcacy-
selective antagonist XLi093, we examined the mechanisms of behavioural eﬀects of diazepam in the tests
of spontaneous locomotor activity and water-maze acquisition and recall, the two paradigms indicative
of sedative- and cognition-impairing eﬀects of BZs, respectively. The locomotor-activity decreasing pro-
pensity of diazepam (signiﬁcant at 1.5 and 5 mg/kg) was antagonized by b-CCt (5 and 15 mg/kg), while it
tended to be potentiated by XLi093 in doses of 10 mg/kg, and especially 20 mg/kg. Diazepam decreased
acquisition and recall in the water maze, with a minimum eﬀective dose of 1.5 mg/kg. Both antagonists
reversed the thigmotaxis induced by 2 mg/kg diazepam throughout the test, suggesting that both GABAA
receptor subtypes participate in BZ eﬀects on the procedural component of the task. Diazepam-induced
impairment in the declarative component of the task, as assessed by path eﬃciency, the latency and
distance before ﬁnding the platform across acquisition trials, and also by the spatial parameters in the
probe trial, was partially prevented by both, 15 mg/kg b-CCt and 10 mg/kg XLi093. Combining a BZ with
b-CCt results in the near to control level of performance of a cognitive task, without sedation, and may be
worth testing on human subjects.
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Introduction
All benzodiazepines (BZs) currently in clinical prac-
tice act as positive modulators of fast inhibitory neu-
rotransmission mediated through those populations
of GABAA receptors which contain a1, a2, a3 or a5
subunits in addition to the c2 subunit (y80% of all
GABAA receptors). The diverse pharmacological ef-
fects of BZs : anxiolytic, sedative, hypnotic, muscle
relaxant, anticonvulsive and amnesic, stem from the
substantial involvement of GABAA receptors in the
regulation of vigilance, anxiety, muscle tension, epi-
leptogenic activity, andmemory functions (Rudolph &
Mo¨hler, 2004 ; Sieghart & Ernst, 2005).
Although very eﬀective in short-term treatment of
diﬀerent psychiatric and neurological ailments (most-
ly anxiety disorders, insomnia, muscle spasms and
epilepsy), BZs are not free of psychomotor and cog-
nitive impairing eﬀects, those prominent being sed-
ation and anterograde amnesia (Lader, 1999). Sedation
is basically related to suppression of the uncon-
ditioned psychomotor performance. Sometimes, the
eﬀect seen after use of certain doses of BZs is an in-
crease, not a decrease of the tracked activity, the
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most parsimonious explanation of this phenomenon
being related to the disinhibitory properties of BZs
(Crawley, 1985). On the other hand, the speciﬁc cog-
nitive eﬀect of BZs appears to be more an impairment
of learning (acquisition) than an eﬀect on memory
(retention) itself, and the term ‘acquisition impairing’
would be more appropriate than ‘amnesic ’ (Clement
& Chapouthier, 1998).
Based on pharmacological studies with ligands with
some degree of GABAA receptor subtype selectivity,
such as CL218,872 and zolpidem (e.g. Depoortere et al.
1986 ; Lippa et al. 1979), it has been hypothesized that
the four populations of BZ-binding site-containing
GABAA receptors, with their distinct patterns of ana-
tomical distribution in the mammalian brain, may
represent diﬀerentiable molecular substrates for the
various eﬀects of BZs. The recent genetic studies with
mice carrying a point mutation (‘knock-in’) of histi-
dine to arginine in a1, a2, a3 or a5 subunits, rendering
the respective GABAA receptors selectively insensitive
to eﬀects of BZs, substantiated the possibility of a
speciﬁc contribution of individual receptor subtypes
to the spectrum of behavioural actions of the reference
BZ, diazepam (reviewed in Rudolph & Mo¨hler, 2004,
2006). The plausibility of selective switching oﬀ of, for
clinical use, mainly unwanted sedative- and acqui-
sition-impairing eﬀects of BZs is highly desirable, and
demands additional knowledge of the molecular and
cellular substrates of these eﬀects. Experimental evi-
dence to date, including the screening of newer aﬃn-
ity- and/or eﬃcacy-selective BZ site ligands, suggests
that GABAA receptors containing a1 and a5 subunits
may be of importance in exerting these two eﬀects in
mutated and wild-type animals (McKernan et al. 2000;
Rudolph et al. 1999 ; Savic´ et al. 2008a ; van Rijnsoever
et al. 2004). Without questioning the main contribution
of the a1 subunit (McKernan et al. 2000, Rudolph et al.
1999), experiments with ligands functionally selective
for a2-, a3- and a5-, or essentially selective for a5-
containing subtypes of GABAA receptors, suggest that
sedation may be partly dependent on activity medi-
ated by a5-containing GABAA receptors (Savic´ et al.
2008a). Moreover, based on inhibitory (Savic´ et al.
2008a, b) or excitatory (Hauser et al. 2005 ; van
Rijnsoever et al. 2004) inﬂuences of modulation of ac-
tivity exerted by neurons expressing the a5-subunit-
containing GABAA receptors on locomotor output,
existence of certain discontinuous ‘eﬀective windows’
of this modulation, which could enable the ‘on/oﬀ
switch’ role of these receptors in control of vigilance,
was proposed (Savic´ et al. 2008b).
On the other hand, behavioural studies with sub-
type selective ligands (Savic´ et al. 2005a, b, 2008b) and
genetically modiﬁed animals (Collinson et al. 2002;
Crestani et al. 2002 ; Rudolph et al. 1999) have indicated
that both, the a1- and a5-subunit-containing GABAA
receptors, comprise the ‘memory-modulating’ popu-
lation of these receptors. It appears that the impairing
eﬀects of BZs on the acquisition of procedural mem-
ory, as assessed in the active avoidance paradigm,
may predominantly depend on the a1-containing
GABAA receptors (Savic´ et al. 2005b), while the inﬂu-
ence on the acquisition of declarative memory, as-
sessed in the passive avoidance paradigm, probably
involves the a5 subunit, in addition to the a1 subunit
(Rudolph et al. 1999 ; Savic´ et al. 2005a).
The aim of the present study was to elucidate, by
the use of two selective ligands, the preferential a1-
subunit aﬃnity-selective antagonist b-CCt, and the a5-
subunit aﬃnity- and eﬃcacy-selective antagonist
XLi093, to what extent GABAA receptors containing
a1 and a5 subunits contribute to the well-established
behavioural eﬀects of diazepam in the tests of spon-
taneous locomotor activity and water-maze acqui-
sition and recall, the two paradigms mainly, but
not exclusively, indicative of sedative- and spatial-
cognition-impairing eﬀects of BZs, respectively. The
selectivity of b-CCt and XLi093 has been conﬁrmed
in in-vitro experiments of aﬃnity and eﬃcacy at re-
combinant GABAA receptors (Huang et al. 2000 ; June
et al. 2003 ; Li et al. 2003), as well as in in-vivo studies of
inhibition of [3H]ﬂumazenil binding in distinct brain
regions, which diﬀer in the GABAA receptor subtype





1,3-propanediyl ester), the a5-subunit aﬃnity- and
eﬃcacy-selective antagonist, and b-CCt (t-butyl-b-
carboline-3-carboxylate), the preferential a1-subunit
aﬃnity-selective antagonist were synthesized at the
Department of Chemistry and Biochemistry, Univer-
sity of Wisconsin–Milwaukee, as described in detail
previously (Cox et al. 1995; Li et al. 2003). Diazepam
was obtained from Galenika (Serbia).
Behavioural experiments
Experiments were carried out on male Wistar rats
(Military Farm, Serbia), weighing 220–250 g. All pro-
cedures in the study conformed to EEC Directive 86/
609 and were approved by the Ethical Committee on
Animal Experimentation of the Faculty of Pharmacy in
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Belgrade. The rats were housed in transparent plastic
cages, six animals per cage, and had free access to
pelleted food and tap water. The temperature of the
animal room was 22¡1 xC, relative humidity 40–70%,
illumination 120 lx, with a 12-h light/dark cycle (lights
on 06:00 hours). All handling and testing took place
during the light phase of the diurnal cycle. Separate
groups of animals were used for two behavioural
paradigms. The behaviour was recorded by a ceiling-
mounted camera and analysed by ANY-maze Video
Tracking System software (Stoelting Co., USA). The
drugs were dissolved/suspended with the aid of son-
ication in a solvent containing 85% distilled water,
14% propylene glycol, and 1% Tween-80, and were
administered in a total volume of 2 ml/kg, 20 min be-
fore behavioural testing. The ﬁrst treatment indicated
in combination was administered into the lower right
quadrant of the peritoneum, and the second treatment
immediately afterwards into the lower left quadrant of
the peritoneum.
Measurement of locomotor activity
Twenty minutes after receiving the appropriate treat-
ment, single rats were placed in a clear Plexiglas
chamber (40r25r35 cm). Activity under dim red
light (20 lx) was recorded for a total of 30 min, without
any habituation period, using ANY-maze software.
Besides the total distance travelled, behaviour was
analysed by dividing the locomotor activity data into
5-min bins.
Two experiments were performed. In the ﬁrst, the
dose–response curve for diazepam (0, 0.5, 1.5, 5.0 mg/
kg) was determined. In the second experiment, the
design included the factors agonist (the same doses of
diazepam as those used in the dose–response study)
and antagonists (b-CCt at 0, 5, 15 mg/kg, and XLi093
at 0, 10, 20 mg/kg), thus generating 20 experimental
groups in total.
Behaviour in the Morris water maze
The water maze consisted of a black cylindrical pool
(diameter 200 cm, height 60 cm), with a uniform inner
surface. The pool was ﬁlled to a height of 30 cm with
water at 23 xC (¡1 xC). The escape platform of black
plastic (15r10 cm) was submerged 2 cm below the
water surface. The platform was invisible to rats by
being the same colour as the pool wall (Terry, 2000).
There were many distal cues in the testing room
(doors, pipes on the walls and the ceiling, cupboards, a
camera suspended above the centre of the maze). An
indirect illumination in the experimental room was
provided by white neon tubes ﬁxed on the walls.
The rats received the appropriate treatment 20 min
before a swimming block, each day for 5 consecutive
days of spatial acquisition. Each block consisted of
four trials, lasting a maximum time of 120 s, the inter-
trial interval being 60 s. For each trial the rat was
placed in the water facing the pool at one of four
pseudo-randomly determined starting positions. As
during spatial learning the platform was hidden in the
middle of the NE quadrant, the four distal start loca-
tions chosen were S, W, NW and SE (Fig. 1). Once the
rat found and mounted the escape platform it was
permitted to remain on the platform for 15 s. The rat
was guided to the platform by the experimenter if it
failed to locate it within 120 s. To assess the long-term
spatial memory at the end of learning, a probe trial for
60 s, with the platform omitted, was given 24 h after
the last acquisition day. The probe trial, starting from
the novel, most distant SW location (in order to ensure
that any spatial bias is a consequence of the spatial
memory of escape location, rather than of a speciﬁc
swim strategy; Vorhees & Williams, 2006), was per-
formed without any pre-treatment. A drug-free probe
trial (cf. McNamara & Skelton, 1993) was chosen be-
cause diazepam impairs acquisition, but not retrieval
of place preference in the water maze (Anand et al.
2007 ; McNamara & Skelton, 1991), and confounding
eﬀects of possible sensorimotor, i.e. non-cognitive ac-
tions of treatment on recall performance were avoided
by such a protocol. The tracking software virtually
divided the pool into four quadrants, three concentric
annuli and a target region consisting of the intersec-
tion of the platform quadrant and the platform annu-















Fig. 1. The scheme representing the virtual division of the
water maze used in the analysis of rats’ performance.
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(1997), the central annulus was set up to 10% of the
whole area ; the platform annulus equalled 40%,
whereas the area of the peripheral annulus was 50% of
the whole.
Dependent variables chosen for tracking during the
acquisition trials were : latency to platform (time from
start to goal), total distance swam (path length), aver-
age swim speed and path eﬃciency (the ratio of the
shortest possible path length to actual path length). All
these indices are, to a lesser or greater degree, related to
goal-directed behaviour, i.e. spatial learning (Vorhees
& Williams, 2006). As thigmotaxis (the tendency to
swim or ﬂoat near the pool wall) represents a factor
which accounts for much of the variance in the water-
maze performance, and normally weakens during
consecutive trials (Vorhees & Williams, 2006), we
quantiﬁed the persistence of thigmotaxis in the target
(NE) quadrant. The loss of thigmotaxis is related to the
procedural component of acquisition, and the percent
of the distance swum in the target region (away from
the wall) of the target quadrant may be seen as a
measure of procedural learning.
The indices of memory, assessed during the probe
trial, included the distance and time in the platform
(target) quadrant, platform ring and target region, as
well as the number of entries and distance swum in
the area where the platform used to be during training
(Fig. 1). In addition, the distance swum during 60 s in
the probe trial was taken as a measure of overall ac-
tivity, while peripheral ring parameters (distance and
time) were connected to thigmotaxic behaviour.
Three experiments in the water maze were per-
formed. In the ﬁrst, the dose–response curve for
diazepam (0, 1, 1.5, 2, 5 mg/kg) was determined. In
the second experiment, the inﬂuences of b-CCt (5,
15 mg/kg) and XLi093 (10, 20 mg/kg) on the eﬀects of
1.5 mg/kg diazepam (the minimal eﬀective dose from
the dose–response study) were assessed. The inclusion
of the groups treated by the antagonists without dia-
zepam would have made the experiment overly long,
on each of ﬁve training days. In preliminary exper-
iments with the current protocol, we noticed the lack
of behavioural activity of higher doses of b-CCt and
XLi093 used here (15, 20 mg/kg, respectively). In the
third water-maze experiment, we assessed the capa-
bility of b-CCt (15 mg/kg) and XLi093 (10 mg/kg) to
antagonize the behavioural eﬀects of a higher dose of
diazepam (2 mg/kg).
Statistical analysis
All numerical data presented in the ﬁgures are given
as the mean¡S.E.M. Data from the activity assay were
assessed by a one-way or two-way ANOVA, whereas
the results from the water-maze test were analysed
using a two-way ANOVA with repeated measures.
Post-hoc comparisons, where applicable, were per-
formed using Student–Newman–Keuls or Dunnett’s
test. Statistical analyses were performed with ANY-




An ANOVA showed a signiﬁcant eﬀect of diazepam
treatment on total distance travelled during 30 min of
monitoring [F(3, 28)=5.63, p=0.004] (Fig. 2a). Accord-
ing to Dunnett’s test, the activity-depressing eﬀect of
two higher doses of diazepam was signiﬁcant com-
pared with solvent control. When the analysis of





















































Sol + DZP 0.5
Sol + DZP 1.5




Fig. 2. The eﬀects of diazepam (Sol+DZP 0.5, 1.5 and 5.0 mg/
kg) on total distance (a) and distance travelled in 5-min
intervals (b). * p<0.05 compared to solvent (Sol+Sol) group;
** p<0.01 compared to solvent. Animals per treatment (n=8).
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(Fig. 2b), it was seen that a dose of 5 mg/kg diazepam
highly signiﬁcantly decreased locomotion in the 0–
15 min period, whereas a dose of 1.5 mg/kg was ef-
fective in the 20–25 min period.
On the other hand, while devoid of discernible ac-
tivity of their own (Figs 3, 4), b-CCt and XLi093 ex-
erted diﬀerential eﬀects on the hypolocomotor eﬀect of
diazepam. Their inﬂuences were evaluated by separ-
ate statistical analyses. A two-way ANOVA for the
analysis of the inﬂuence of b-CCt has shown a signiﬁ-
cant eﬀect of dose of diazepam [F(3, 71)=3.95, p=
0.012], whereas the dose of antagonist as a factor,
as well as the agonistrantagonist interaction did not
reach signiﬁcance [F(2, 60)=2.30, p=0.109; F(6, 71)=
0.49, p=0.811, respectively]. Post-hoc Student–
Newman–Keuls method revealed that the existing
signiﬁcant diﬀerences between the levels of diazepam



































































































































































Fig. 3. The eﬀects of combinations of diazepam (DZP), at doses of 0, 0.5, 1.5 and 5.0 mg/kg, and the antagonists b-CCt (0, 5,
15 mg/kg) and XLi093 (0, 10, 20 mg/kg), on total distance travelled in the spontaneous locomotor activity test. * p<0.05,
compared to solvent (Sol+Sol) group; + p<0.05 compared to DZP 0.5+Sol group; ## p<0.01 compared to XLi093 10+Sol















































0 5 10 15 20 25 30
Time (min) Time (min)
0 5 10 15 20 25 30
Sol + Sol
βCCt 5 + Sol
βCCt 15 + Sol
XLi093 10 + Sol
XLi093 20 + Sol
Sol + Sol
DZP 1.5 + Sol
DZP 1.5 + βCCt 5
DZP 1.5 + βCCt 15
DZP 1.5 + XLi093 10
DZP 1.5 + XLi093 20
Sol + Sol
DZP 0.5 + Sol
DZP 0.5 + βCCt 5
DZP 0.5 + βCCt 15
DZP 0.5 + XLi093 10
DZP 0.5 + XLi093 20
Sol + Sol
DZP 5.0 + Sol
DZP 5.0 + βCCt 5
DZP 5.0 + βCCt 15
DZP 5.0 + XLi093 10
DZP 5.0 + XLi093 20
Fig. 4.Mean distance travelled in successive 5-min blocks for groups designated as in Fig. 3.
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when multiple comparisons were made within the
5 mg/kg b-CCt dose (respective p values 0.419 and
0.339), as well as within the 15 mg/kg b-CCt level
(respective p values 0.251 and 0.302). When analysing
the overall inﬂuence of XLi093 as antagonist, there was
a signiﬁcant eﬀect of dose of diazepam [F(3, 71)=
15.323, p<0.001], whereas dose of XLi093 as a factor,
as well as the agonistrantagonist interaction were
insigniﬁcant [F(2, 60)=0.806, p=0.451; F(6, 71)=0.846,
p=0.540, respectively]. Contrary to the antagonism
exerted by b-CCt, post-hoc analysis revealed that the
existing eﬀects of diazepam (5 vs. 0 mg/kg, p=0.027; 5
vs. 0.5 mg/kg, p=0.041) were potentiated by XLi093
(Fig. 3). Namely, comparisons within the 10 mg/kg
XLi093 level have shown highly signiﬁcant diﬀerences
in the eﬀects of 1.5 and 5 mg/kg doses of diazepam vs.
the eﬀect of the antagonist itself (p=0.003 in both
cases), whereas within the dose of 20 mg/kg XLi093,
all three levels of diazepam (0.5, 1.5, 5 mg/kg) were
statistically diﬀerent from the antagonist (respective
p values : 0.013, 0.002,<0.001). Similar conclusions can
be reached while statistically analysing (not shown)
the data obtained by dividing the locomotor activity
into 5-min bins (Fig. 4). As a rule, locomotor activity
of animals treated with combination of diazepam+
b-CCt, irrespective of the dose employed, was near to,
or slightly above, the control value, whereas XLi093,
especially at the higher dose, tended to deepen, or
unveil, the sedation induced by diazepam.
Morris water maze
For the dose–response study of diazepam, the factors
treatment and days, as well as the interaction treat-
mentrdays, were statistically highly signiﬁcant for
the latency to ﬁnd platform, the distance swum before
ﬁnding the platform, swim speed and path eﬃciency;
signiﬁcant diﬀerences among treatments during train-
ing days are presented in Fig. 5. The results of the post-
hoc analysis for the factor treatment are summarized in
Table 1. The analysis showed that the lowest eﬀective



















































































DZP 1.0 + Sol
DZP 1.5 + Sol
DZP 2.0 + Sol
DZP 5.0 + Sol
Sol + Sol
DZP 1.0 + Sol
DZP 1.5 + Sol
DZP 2.0 + Sol
DZP 5.0 + Sol
Sol + Sol
DZP 1.0 + Sol
DZP 1.5 + Sol
DZP 2.0 + Sol
DZP 5.0 + Sol
Sol + Sol
DZP 1.0 + Sol
DZP 1.5 + Sol
DZP 2.0 + Sol












































































Fig. 5. The eﬀects of diazepam 1.0, 1.5, 2.0 and 5.0 mg/kg (DZP 1.0+Sol to DZP 5.0+Sol) on (a) latency to platform, (b) total
distance, (c) average swim speed and (d) path eﬃciency of rats during 5 d acquisition trials in the water maze. * p<0.05,
** p<0.01, *** p<0.001 compared to solvent (Sol+Sol) group; +p<0.05, ++ p<0.01, +++ p<0.001 compared to DZP 1.0+Sol
group; # p<0.05, ## p<0.01, ### p<0.001 compared to DZP 1.5+Sol group; # p<0.05, ## p<0.01 compared to DZP 2.0+Sol group.
Animals per treatment (n=7).






/ijnp/article-abstract/12/9/1179/666682 by Belgrade U
niversity user on 31 July 2019
The incapacitating inﬂuences of previous treatment
with diazepam were also discernible during the probe
trial (Table 2), when a number of indices of memory
(time in platform quadrant, time and distance in
platform ring, time and distance in target region) were
dose-dependently adversely aﬀected. Concomitantly,
a signiﬁcant increase of peripheral ring parameters,
i.e. pronounced thigmotaxis (Table 2), has conﬁrmed
Table 1. Signiﬁcant diﬀerences among overall inﬂuences (averaged for 5 d acquisition) on the water-maze learning
parameters : latency to ﬁnd the platform (L), distance swam before ﬁnding the platform (D), mean swim speed (S) and path
eﬃciency (E) in the dose–response study of diazepam (DZP, mg/kg)
DZP 1.0+Sol DZP 1.5+Sol DZP 2.0+Sol DZP 5.0+Sol
Sol+Sol L : p=0.004 L : p<0.001 L: p<0.001 L : p<0.001
D: p<0.001 D: p=0.001 D: p=0.002
E : p<0.001 E: p<0.001 S : p<0.001
E : p<0.001
DZP 1.0+Sol L : p<0.001 L: p=0.001 L : p<0.001
D: p=0.002 D: p=0.014 D: p=0.030
E : p=0.001 E: p=0.001 S : p<0.001
E : p=0.001
DZP 1.5+Sol L : p=0.007
S : p<0.001
DZP 2.0+Sol L : p=0.002
S : p<0.001
Sol, Solvent.
Table 2. The representative parameters of water-maze performance in the probe trial of the diazepam (DZP, mg/kg)
dose-response experiment. The key to regions used in the analysis is given in Fig. 1.
Sol+Sol DZP 1.0+Sol DZP 1.5+Sol DZP 2.0+Sol DZP 5.0+Sol
ANOVA
F(4, 30) p
Whole water maze parameters
Distance (m) 13.97¡1.19 11.54¡0.48 15.01¡1.26 14.51¡0.78 13.70¡0.69 2.051 0.112
Platform quadrant (NE) parameters
Distance (m) 3.87¡0.45 2.33¡0.39 2.92¡0.34 2.95¡0.37 2.34¡0.36 2.661 0.052
Time (s) 16.26¡1.42 11.44¡1.98 11.29¡1.23 11.94¡1.50 8.63¡1.38* 3.255 0.025
Peripheral ring parameters
Distance (m) 6.67¡0.95 5.34¡1.13 11.79¡1.67*++ 10.67¡0.77*++ 10.62¡0.46*++ 6.914 <0.001
Time (s) 30.61¡2.37 29.41¡5.33 48.44¡3.30**++ 47.33¡2.75**++ 50.19¡1.95**++ 9.361 <0.001
Platform ring parameters
Distance (m) 6.09¡0.75 5.00¡0.61 2.59¡0.82** 3.26¡0.61* 2.69¡0.51** 5.371 0.002
Time (s) 24.79¡2.37 24.90¡3.67 9.43¡2.72**++ 10.73¡2.37**++ 8.63¡1.65**++ 10.100 <0.001
Target region parameters
Distance (m) 2.00¡0.26 1.01¡0.20** 0.40¡0.12*** 0.67¡0.20*** 0.55¡0.20*** 10.108 <0.001
Time (s) 7.81¡1.24 4.59¡0.92* 1.36¡0.41***+ 2.14¡0.74***+ 1.64¡0.60***+ 10.704 <0.001
Platform parameters
No. of entries 1.00¡0.38 0.43¡0.20 0.00¡0.00 0.43¡0.30 0.29¡0.18 2.167 0.097
Distance (m) 0.102¡0.042 0.043¡0.022 0.000¡0.000 0.047¡0.034 0.012¡0.008 2.261 0.086
Values are mean¡S.E.M.
* p<0.05, ** p<0.01, *** p<0.001, compared to solvent (Sol+Sol) group.
+ p<0.05, ++ p<0.01, compared to DZP 1.0+Sol group.
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that learning the required water-maze skills and stra-
tegies was impaired under diazepam.
Based on the presented dose–response study, we
performed a further experiment in which two doses of
each of the antagonists, tested in the locomotor activity
assay, were combined with 1.5 mg/kg diazepam.
However, in this experiment, the eﬀect of diazepam
did not reach signiﬁcance compared with control, for
any of the learning measures calculated. A two-way
ANOVA with repeated measures for this antagon-
ism study revealed signiﬁcant variability in regard to
latencies to ﬁnd the platform [treatment eﬀect :
F(5, 138)=6.59, p<0.001 ; day eﬀect : F(4, 552)=50.39,
p<0.001 ; and treatmentrday interaction : F(20, 552)=
1.80, p=0.018] and path eﬃciencies across the 5 d
[treatment eﬀect : F(5, 138)=4.67, p=0.001; day eﬀect :
F(4, 552)=17.61, p<0.001 ; treatmentrday interaction:
F(20, 552)=1.88, p=0.012]. The respective signiﬁcant
diﬀerences among treatments during days are pre-
sented in Fig. 6(a, d). The factors, but not the interac-
tion, also reached signiﬁcance when swim distances
(Fig. 6b) and average swim speed (Fig. 6c) were
analysed [treatment eﬀect : F(5, 138)=5.42, p<0.001;
day eﬀect : F(4, 552)=34.27, p<0.001 ; treatmentr
day interaction : F(20, 552)=1.50, p=0.075; and treat-
ment eﬀect : F(5, 138)=5.02, p<0.001; day eﬀect :
F(4, 552)=21.08, p<0.001 ; treatmentrday interaction:
F(20, 552)=1.22, p=0.233, respectively]. Bearing in
mind especially the latency to platform (Fig. 6a), it
appears that antagonism of the eﬀects of diazepam at
GABAA receptors containing a5 subunits (1.5 mg/kg
diazepam+10 mg/kg XLi093) may enhance acqui-
sition in the earliest stages of spatial learning, while
addition of a higher dose of the antagonist (1.5 mg/kg
diazepam+20 mg/kg XLi093) may even impair the
later phases of learning. Throughout the acquisition
trials, there were no discernible eﬀects of adding bCCt,
at either dose, to diazepam. In the probe trial, the sig-
niﬁcant diﬀerences in dependent measures of per-
formance were generally absent, probably due to the
lack of clear behavioural activity of the used dose of
diazepam, and these data are not presented.
Finally, the results of the experiment with a higher
eﬀective dose of diazepam (2 mg/kg), on its own and
in combination with 10 mg/kg XLi093 and 15 mg/kg
bCCt are shown in Figs 7 and 8, and Tables 3 and 4.
A two-way ANOVA with repeated measures of lat-
encies to ﬁnd the platform across the 5 d (Fig. 7a)
revealed the following results [treatment eﬀect :
F(3, 100)=11.65, p<0.001; day eﬀect : F(4, 400)=56.74,
p<0.001 ; treatmentrday interaction: F(12, 400)=0.96,
p=0.484]. Similar tendencies were evident when swim
distances (Fig. 7b) and path eﬃciencies (Fig. 7d) were
analysed [treatment eﬀect : F(3, 100)=6.34, p=0.001;
day eﬀect : F(4, 400)=28.17, p<0.001; treatmentrday
interaction : F(12, 400)=1.46, p=0.135; and treat-
ment eﬀect : F(3, 100)=5.98, p=0.001 ; day eﬀect :
F(4, 400)=27.68, p<0.001 ; treatmentrday interaction:
F(12, 400)=1.03, p=0.422, respectively]. The interac-
tion only reached signiﬁcance when swim speed was
analysed [treatment eﬀect : F(3, 100)=6.29, p=0.001;
day eﬀect : F(4, 400)=14.03, p<0.001; treatmentrday
interaction : F(12, 400)=1.92, p=0.031], and signiﬁcant
diﬀerences among treatments during days are given in
Fig. 7c. As treatment as a factor was statistically sig-
niﬁcant for all four learning parameters illustrated, the
respective signiﬁcances for single treatments are
shown in the Table 2. bCCt (15 mg/kg) completely
prevented acquisition-impairing actions of diazepam
administered at the dose of 2 mg/kg, whereas ad-
dition of XLi093 (10 mg/kg) was eﬀective in this sense
for all parameters considered, with the exception of
the mean swim speed (Table 3). It should be noted that
statistical analysis revealed no overall signiﬁcant dif-
ference in maximum speed in treatments ; moreover,
on the ﬁrst day, the rats treated with diazepam were
even faster, in maximum, than control rats (1.16¡
0.44 m/s vs. 0.78¡0.14 m/s), which is a hint of tran-
sient behavioural disinhibition.
In Fig. 8, the distances the rats swam in the platform
quadrant (NE) during acquisition trials are presented
alongside the respective distance in the portion of NE
quadrant lying in the platform annulus of the maze
(‘the target region’). The rats treated with 2 mg/kg
diazepam strikingly lacked the preferential activity in
that part of the NE quadrant in which platform ﬁnding
was possible ; even on day 5, only 49.4% of the dis-
tance they travelled in NE quadrant was in the target
region; the respective values for control, 2 mg/kg
diazepam+15 mg/kg bCCt and 2 mg/kg diazepam+
10 mg/kg XLi093 groups were 75.4%, 82.9% and
69.8%.
In Table 4, a number of parameters calculated from
the probe trial performance in the antagonism study
with 2 mg/kg diazepam are presented. The total dis-
tance swum was not diﬀerent, and there were also no
signiﬁcant diﬀerences among groups regarding dis-
tance and time spent in the platform quadrant. On the
other hand, animals treated for 5 d with diazepam
exerted a strong bias towards the peripheral annulus,
which was reversed by both antagonists. Concomi-
tantly, previous treatment with diazepam resulted in
signiﬁcant avoidance of the platform annulus, which
was also antagonized by both, bCCt (15 mg/kg) and
XLi093 (10 mg/kg). The changes of these two para-
meters are indicative of inﬂuences on the previous
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days’ behavioural strategies learning, i.e. the pro-
cedural component of water-maze spatial memory.
There were no signiﬁcant diﬀerences in target region
activity, whereas diazepam treatment tended to de-
crease platform site entries and signiﬁcantly decreased
the distance in platform position. The latter eﬀect, in-
dicative of inﬂuence on the declarative spatial com-
ponent of memory, was attenuated, but not reversed,
by both antagonists.
Discussion
The a1- and a5-containing GABAA receptors have been
repeatedly implicated, to a diﬀerent degree, in me-
diation or modulation of widely known sedative and
amnesic eﬀects of agonists at BZ-sensitive GABAA re-
ceptors (McKernan et al. 2000 ; Rudolph et al. 1999 ;
Savic´ et al. 2008a ; van Rijnsoever et al. 2004). The
present experiments, using the selective antagonists at
BZ site of a1- and a5-containing GABAA receptors,
demonstrated that the activity-decreasing propensity
of diazepam, as a measure of sedation, is the conse-
quence of its binding at a1-containing GABAA re-
ceptors, whereas spatial learning and memory deﬁcits
induced by diazepam are related to action at both of
these receptor populations.
The ﬁndings in the motor activity assay on the pre-
dominant role of a1 GABAA receptors are in accord
with genetic studies (McKernan et al. 2000 ; Rudolph
et al. 1999). What appears to be the most surprising
result of this part of the study, combining diazepam
with XLi093, especially with the higher (20 mg/kg) of
the two tested doses of the antagonist, potentiated
sedation induced by diazepam. The 20 mg/kg dose of
XLi093 presumably caused a complete antagonism of
eﬀects of diazepam at a5-containing GABAA receptors
(cf. occupancy of about 65% of a5 GABAA receptors
in mice at 10 mg/kg XLi093 in Shinday et al. 2008).
We have recently put forward the hypothesis that
locomotor-activity changes induced by ligands pos-
sessing a substantial a5 eﬃcacy may be, at least partly,
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Fig. 6. The eﬀects of diazepam (DZP 1.5+Sol), diazepam and b-CCt (DZP 1.5+b-CCt 5 and DZP 1.5+b-CCt 15) and diazepam
and XLi093 (DZP 1.5+XLi093 10 and DZP 1.5+XLi093 20) (all doses in mg/kg) on (a) latency to platform, (b) total distance,
(c) average swim speed and (d) path eﬃciency of rats during 5 d acquisition trials in the water maze. * p<0.05, ** p<0.01
compared to solvent (Sol+Sol) group; + p<0.05 compared to DZP 1.0+Sol group; # p<0.05, ## p<0.01 compared to DZP
1.5+b-CCt 5 group; # p<0.05, ## p<0.01 compared to DZP 1.5+b-CCt 15 group. Animals per treatment (n=6).
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containing this subunit (Savic´ et al. 2008a). It appears
that the role of positive modulation at a5 GABAA re-
ceptors depends on the concomitant activity at
a1-containing GABAA receptors. Moreover, a5 GABAA
receptors may exert a dual control on the state of vig-
ilance : to limit sedative eﬀects elicited by supra-
physiological stimulation of a1-containing receptors,
and, conversely, to enhance basal/endogenous acti-
vation of a1 GABAA receptors, thereby inducing mild
sedation. Three sets of data may indirectly support
the notion of the modulatory role of this population
of receptors. First, it is notable that a5-containing
GABAA receptors are at least moderately present in
both regions believed to be involved in the sedative
properties of GABAA receptor activators (Hentschke
et al. 2005 ; Kiehn, 2006), i.e. ventral horn of the
spinal cord (Bohlhalter et al. 1996), and pyramidal
neurons of the neocortex, especially layer V (Pirker
et al. 2000 ; Yamada et al. 2007). Second, there is a con-
spicuous association between a1 and a5 subunits : the
co-localization within individual neurons (Bohlhalter
et al. 1996), and even within the single GABAA recep-
tor (Araujo et al. 1999). Third, the knock-in mice har-
bouring the a5 subunit insensitive to diazepam are
refractory to development of tolerance to the a1-
mediated sedative eﬀect of diazepam at subchronic
doses (van Rijnsoever et al. 2004).
The eﬀects of diazepam on the acquisition and re-
tention of place learning in the water maze have been
previously assessed in two settings, similar but not
identical to the present procedure (Arolfo & Brioni,
1991 ; Cain, 1997). The lowest dose eﬀective in our ex-
periment (1.5 mg/kg) lies between those found by
Arolfo & Brioni (1.0 mg/kg) and Cain (3.0 mg/kg
diazepam). However, the antagonism study showed
that the 1.5 mg/kg dosage level was a borderline dose
of diazepam, unreliable in aﬀecting rats’ behaviour
under the conditions used in the current water-maze
protocol. Nevertheless, in such settings, an impair-
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Fig. 7. The eﬀects of diazepam (DZP 2+Sol), diazepam and b-CCt (DZP 2+b-CCt 15) and diazepam and XLi093 (DZP
2+XLi093 10) (all doses in mg/kg) on (a) latency to platform, (b) average total distance, (c) average swim speed and (d) path
eﬃciency of rats during 5 d acquisition trials in the water maze. * p<0.05 compared to solvent (Sol+Sol) group; + p<0.05
compared to DZP 2+Sol group; # p<0.05 compared to DZP 2+b-CCt 15 group. Animals per treatment, for Sol+Sol to DZP
2+XLi093 10 (n=6, 6, 7, 7, respectively).
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produced by the combination of diazepam (1.5 mg/
kg) and the higher dose of XLi093 (20 mg/kg) was
revealed. We hypothesize that this ﬁnding may be
connected with the profound sedation observed with
the same combination in the procedure measuring
locomotor activity. Namely, it is possible (cf. van
Rijnsoever et al. 2004) that the supposed complete an-
tagonism at a5-containing GABAA receptors forestalls
development of tolerance to sedation and/or de-
creased vigilance, and hence impairs learning; this
question could be partly resolved with further studies
of repeated dosing of diazepam and XLi093 in the
locomotor activity test.
In the antagonism study with 2.0 mg/kg diazepam,
both antagonists tended to reverse its eﬀects, which
may be seen as corroborating previous conclusions
that the water-maze acquisition impairment is not
due to the sedative eﬀect of diazepam (McNamara &
Skelton, 1991). The fact that rats treated with the
combination 2 mg/kg diazepam+15 mg/kg b-CCt
were even faster swimmers, overall, than the group
treated with diazepam and the group treated with the
combination 2 mg/kg diazepam+10 mg/kg XLi093,
replicates our previous ﬁnding with the combination
of 2 mg/kg midazolam+30 mg/kg b-CCt, which po-
tentiated inter-trial crossings during the acquisition
session of active avoidance paradigm (Savic´ et al.
2005b). In regard to the cognitive function-related
parameters, b-CCt antagonized the inhibitory eﬀect
of midazolam on procedural memory tested through
active avoidance retention (Savic´ et al. 2005b), and at-
tenuated the deteriorating eﬀect of the BZ on declara-
tive memory in passive avoidance paradigm (Savic´
et al. 2005a). In the anxiety-related paradigms (elev-
ated plus maze and acquisition session of active
avoidance), potentiation of the anti-anxiety action
of midazolam was observed (Savic´ et al. 2004, 2005b).
As the emotionally arousing experiences tend to be
well remembered (McGaugh, 2004), it is widely ac-
cepted that suppression of arousal and anxiety by BZs
may impair some aspects of cognitive functioning
(Curran, 1991). However, the present water maze re-
sults, together with the previous ﬁndings, dismiss
the suggestion (Zanotti et al. 1994) that the diazepam-
induced place learning impairment may be mainly
related to its anxiolytic properties. Despite the fact that
the anti-anxiety eﬀect of diazepam may have only
been preserved or potentiated, not abolished, by
b-CCt, the overall performance during ﬁve acquisition
days was at least equal to that of the control group.
The present and previous results suggest that com-
bining a BZ with b-CCt may result in a near to control


















































28.7% 51.1% 66.2% 72.3% 75.4%
14.3% 18.9% 28.5% 42.1% 49.4%
39.1% 71.7% 78.1% 76.5% 82.3%
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Acquisition days
Sol + Sol
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Distance in NE quadrant
Distance in target region
Fig. 8. The eﬀects of (a) solvent (Sol+Sol) ; (b) diazepam
(DZP 2+Sol), (c) diazepam and b-CCt (DZP 2+b-CCt 15) and
(d) diazepam and XLi093 (DZP 2+XLi093 10) (all doses in
mg/kg) on the distance rats travelled in the SE quadrant and
target region during 5 d acquisition trials in the water maze.
The numbers inside the columns are the percent of the
distance swam inside the target (NE) quadrant which was
travelled in the target region.
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sedation, but with highly desirable preserved anti-
anxiety activity.
On the other hand, Cain (1997) suggested that the
acquisition deﬁcits may result from the sensorimotor
disturbances that diazepam causes. Namely, the au-
thor found that non-spatial pretraining without pre-
treatment eliminated swimming in the periphery of
the pool, platform deﬂections and swimovers, and re-
sulted in the normal, rapid acquisition of the water-
maze task under diazepam (Cain, 1997). Nevertheless,
McNamara & Skelton (1991) found that treatment
with diazepam after the rats acquired the location of
the platform did not aﬀect further water-maze ac-
tivity, while it did impair ﬁnding of the newly located
platform. Bearing in mind the interaction between
arousal, cognitive function and anxiety (Curran, 1991),
it is diﬃcult to say that the present results support the
view of either pure learning-impairing (McNamara &
Skelton, 1991) or non-selective incapacitating (Cain,
1997) eﬀects of diazepam as the explanation for its
Table 3. Signiﬁcant diﬀerences among overall inﬂuences (averaged for 5 d of
acquisition) of the tested treatments (mg/kg) on the water-maze learning
parameters : latency to ﬁnd the platform (L), distance swam before ﬁnding the
platform (D), mean swim speed (S) and path eﬃciency (E)
Sol+Sol DZP 2+bCCt 15 DZP 2+XLi093 10
DZP 2+Sol L : p<0.001 L : p<0.001 L : p=0.002
D: p=0.001 D: p=0.001 D: p=0.011
E : p=0.024 S : p=0.001 E : p=0.025
E : p<0.001
DZP 2+XLi093 10 S : p=0.005
DZP, Diazepam; Sol, solvent.
Table 4. The representative parameters of water-maze performance in the probe trial. The key to regions used in the analysis
is given in Fig. 1
Sol+Sol DZP 2+Sol DZP 2+bCCt 15 DZP 2+XLi093 20 ANOVA, F p
Whole water maze parameters
Distance (m) 10.74¡1.62 11.74¡0.40 12.45¡0.58 11.43¡0.96 0.531 0.67
Platform quadrant (NE) parameters
Distance (m) 2.11¡0.48 2.39¡0.28 1.72¡0.47 1.65¡0.29 0.522 0.52
Time (s) 10.50¡2.05 11.98¡1.59 7.33¡2.13 9.31¡2.06 0.971 0.42
Peripheral ring parameters
Distance (m) 3.80¡0.99 7.86¡0.84** 5.16¡0.60+ 5.11¡0.61+ 4.77 0.010
Time (s) 29.45¡4.18 44.82¡2.39** 29.19¡2.81++ 32.20¡2.42++ 5.81 0.004
Platform ring parameters
Distance (m) 6.26¡0.91 2.98¡0.55* 6.03¡0.50+ 5.08¡0.71+ 4.62 0.012
Time (s) 27.05¡3.19 11.75¡2.32** 25.87¡1.98++ 22.31¡2.29++ 7.66 0.001
Target region parameters
Distance (m) 1.48¡0.44 0.78¡0.26 1.06¡0.22 1.12¡0.27 0.86 0.48
Time (s) 5.63¡1.82 3.20¡1.09 3.94¡1.05 4.79¡1.24 0.61 0.62
Platform parameters
No. of entries 1.33¡0.49 0.17¡0.17 0.57¡0.20 0.86¡0.26 2.52 0.084
Distance (m) 0.146¡0.051 0.007¡0.007* 0.051¡0.019 0.076¡0.034 3.11 0.047
DZP, Diazepam; Sol, solvent.
Values are mean¡S.E.M.
DZP, bCCt, XLi093 treatments in mg/kg.
* p<0.05 compared to solvent (Sol+Sol) group; ** p<0.01 compared to solvent ; + p<0.05 compared to DZP 2 mg/kg group
(DZP 2+Sol) ; ++ p<0.01 compared to DZP 2 mg/kg group.
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eﬀects on spatial learning. Both types of inﬂuences
may be partly operating in the learning impairment
induced by diazepam in the Morris water maze.
The results from the probe trial show that the plat-
form quadrant parameters are not a reliable measure
of spatial memory inﬂuences at the used doses of
diazepam (cf. Gerlai, 2001). As an example, rats trea-
ted during previous days with 2.0 mg/kg diazepam
spent three quarters of the probe trial time in balanced
circling throughout the peripheral annulus, and it was
not possible to detect any lack of preference for the
target quadrant during the 15 s of rest. Suppression
of an instinct to swim thigmotaxically appears to be
necessary to eﬀectively accomplish the maze task
(Cain, 1998). b-CCt as well as XLi093 reversed both the
increase of peripheral annulus and the decrease of
platform annulus parameters, induced by 2 mg/kg
diazepam. The results from the recall trial as well as
from acquisition trials suggest that it is suﬃcient to
antagonize the activity of diazepam at either a1- or
a5-containing GABAA receptors in order to forestall
its inﬂuence on learning the required water-maze
skills and strategies, i.e. procedural components of this
memory task (Cain, 1998 ; Rossato et al. 2006).
Despite the expected relatively low control group
activity in the platform zone on its own (cf. Vorhees &
Williams, 2006), the anterograde amnesic inﬂuence of
previous treatment with 2 mg/kg diazepam still
reached statistical signiﬁcance, and was only partially
prevented by both antagonists used, i.e. they atte-
nuated, but did not antagonize, the spatial memory
deﬁcit. In fact, the parameters related to the previous
platform location in the probe trial are the only ones in
the antagonism study with 2 mg/kg diazepam which
did not tend to be at least a little more preserved in
combination with b-CCt than with XLi093. The water
maze is usually seen as a hippocampal-dependent
memory model (Gerlai, 2001), and abundant staining
in the rat hippocampus was shown for the a1 as well as
a5 subunit (Pirker et al. 2000). There are several ex-
perimental ﬁndings related to the role of the a5 subunit
in spatial memory. Thus, the a5 knockout mice, com-
pared to the wild-type animals, performed signiﬁ-
cantly better in a working-memory protocol of the
water maze (Collinson et al. 2002), while an inverse
agonist selective for GABAA receptors containing a5
subunits facilitated the acquisition and recall of rats in
a similar protocol of working memory (Collinson et al.
2006). The present protocol enabled the long-term
consolidation of spatial memory to happen, therefore
it can be hypothesized that potentiation of inhibitory
transmission at both, the a5- and a1-containing
GABAA receptors contributes in an interactive way to
impairment in the declarative spatial component of
the task (Cain, 1998 ; Rossato et al. 2006). It is conceiv-
able that besides the hippocampus, with its crucial role
in long-term spatial memory (Bird & Burgess, 2008),
the a1- and a5-containing GABAA receptors in neo-
cortex (Pirker et al. 2000 ; Yamada et al. 2007) may be of
signiﬁcance for spatial memory deﬁcits induced by
diazepam.
Curran (1991) concluded that sedative eﬀects of BZs
in humans are much more easily reversed than am-
nesic eﬀects ; a similar conclusion may have been ap-
plied to rats’ behaviour in the active avoidance task
(Savic´ et al. 2005b) and to a certain degree to the pres-
ent results. It appears that the procedural component
(strategy learning) of the water-maze learning deﬁcit
induced by diazepam is more prone to reversion by
a1- and a5-subtype selective antagonists, the role of a1-
containing GABAA receptors being more salient, while
the declarative spatial memory component of learning
deﬁcit is less prone to attenuation by antagonists, and
may be more related to a5-containing GABAA re-
ceptors. Considering the previous results with the
combination of a non-selective BZ site agonist and
the a1 selective antagonist b-CCt (Savic´ et al. 2004,
2005a, b), it appears that behavioural eﬀects of such a
polypharmacy approach may be highly attractive. In
the quest for anxioselective anxiolytics, such a combi-
nation may be worth testing on human subjects, and it
could be especially useful in treating those forms of
emotional disorders which are accompanied by psy-
chomotor eﬀects.
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